ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Ethyl Acetate → 7-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetamido]-3-[3-(3-formylaminopyridinio)-1-propen-1-yl]-3-cephem-4-carboxylate

HRID 580198
ノート
印刷プレビュー

反応式

HRID 580198 の反応式
[NH2:1][C:2]1[S:6][N:5]=[C:4]([C:7](=[N:40][O:41][CH3:42])[C:8]([NH:10][CH:11]2[C:38](=[O:39])[N:13]3[C:14]([C:22]([O:24]C(C4C=CC=CC=4)C4C=CC=CC=4)=[O:23])=[C:15]([CH:18]=[CH:19][CH2:20]I)[CH2:16][S:17][C@H:12]23)=[O:9])[N:3]=1.[CH:43]([NH:45][C:46]1[CH:47]=[N:48][CH:49]=[CH:50][CH:51]=1)=[O:44].C(OCC)(=O)C>CS(C)=O>[NH2:1][C:2]1[S:6][N:5]=[C:4]([C:7](=[N:40][O:41][CH3:42])[C:8]([NH:10][CH:11]2[C:38](=[O:39])[N:13]3[C:14]([C:22]([O-:24])=[O:23])=[C:15]([CH:18]=[CH:19][CH2:20][N+:48]4[CH:49]=[CH:50][CH:51]=[C:46]([NH:45][CH:43]=[O:44])[CH:47]=4)[CH2:16][S:17][C@H:12]23)=[O:9])[N:3]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 8857Ethyl AcetateHCID 3815043N-Pyridin-3-yl-formamideHCID 131715581Diphenylmethyl 7-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetamido]-3-(3-iodo-1-propen-1-yl)-3-cephem-4-carboxylate

生成物 1

HCID 1317155867-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetamido]-3-[3-(3-formylaminopyridinio)-1-propen-1-yl]-3-cephem-4-carboxylate収率 2.9%

試薬・触媒・溶媒 1

HCID 679
Dimethyl Sulfoxide
溶媒

実験手順

A mixture of diphenylmethyl 7-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetamido]-3-(3-iodo-1-propen-1-yl)-3-cephem-4-carboxylate (IX-1) (E, 716 mg, 1 mmole) and 3-formylaminopyridine [prepared according to the procedure of N. Enomoto et al., Bull. Chem. Soc. Japan, 45, 2665 (1972)] (244 mg, 2 mmoles) in DMSO (2 ml) was stirred at room temperature for 1 hour, and poured into ethyl acetate (200 ml). The precipitate was collected by filtration, washed well with ethyl acetate and dried. A mixture of the quaternized salt (500 mg) and sodium bisulfite (50 mg) in HCOOH (5 ml) was stirred at 40°-50° C. for 80 minutes and evaporated to dryness in vacuo. The residue was dissolved in water (40 ml), neutralized with NaHCO3 and then filtered to remove insoluble material. The clear filtrate was chromatographed on a reverse phase column, PrepPAK-500/C18 (100 ml), with water and 5% CH3OH, 10% CH3OH, 20% CH3OH and 30% CH3OH. The fractions containing the desired compound were combined, concentrated in vacuo and lyophilized to give 16 mg (2.9%) of the title compound (I-1F) (E) as a tan powder. Mp. >170° C. (dec.).

後処理

  1. customprepared
  2. filtrationThe precipitate was collected by filtration
  3. washwashed well with ethyl acetate
  4. customdried
  5. additionA mixture of the quaternized salt (500 mg) and sodium bisulfite (50 mg) in HCOOH (5 ml)
  6. customevaporated to dryness in vacuo
  7. dissolutionThe residue was dissolved in water (40 ml)
  8. filtrationfiltered
  9. customto remove insoluble material
  10. customThe clear filtrate was chromatographed on a reverse phase column
  11. additionThe fractions containing the desired compound
  12. concentrationconcentrated in vacuo

出典と根拠

ORDレコード
ord-f5d44138e06d41af98dd3c0b97fd05ca
出典データセット
uspto-grants-1988_06
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US04751295

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート